Back

Targeting alpha 5 beta 1 integrin as a therapeutic strategy to combat right ventricular dysfunction in pulmonary arterial hypertension

29 August 2025 (08:35 - 08:45)
Organised by: Logo
Congress Presentation Part of: Pathobiology of pulmonary hypertension Pathophysiology and Mechanisms ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Miss Sarah-Eve Lemay

Quebec (Canada)

4 More presentations in this session

Presentation thumbnail
The interaction of bone morphogenetic protein receptor type 2 and pentraxin 3 on inflammation and fibrosis: implications for pulmonary hypertension
Professor P. Liu (Tainan, TW)
Abstract Slides Video
Presentation thumbnail
Spatial proteomics unveils region-specific alterations in right ventricular remodeling rats under pressure overload
Ms J. Zhang (Beijing, CN)
Abstract Slides Video
Presentation thumbnail
ROBO4 triggers pulmonary arterial hypertension through promoting the progressive reduction of pulmonary micro-vessels and the remodeling of distal pulmonary arterioles
Associate Professor X. Zou (Hangzhou, CN)
Abstract Slides Video
Presentation thumbnail
Comparative analysis of microRNA expression in idiopathic pulmonary arterial hypertension and Eisenmenger syndrome: Insights into vascular remodeling and disease progression
Doctor D. Miskowiec (Lodz, PL)
Abstract Slides Video

Access the full session

Session thumbnail
Pathobiology of pulmonary hypertension
Video

The Event

Event poster

ESC Congress 2025

29 August 2025 08:35 CET
You may be interested in
thumbnail
Congress Session
Pathobiology of pulmonary hypertension
thumbnail
Congress Session
Molecular approaches to the treatment of pulmonary hypertension
thumbnail
Congress Session
Young Investigator Award (YIA) Basic Science

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources